{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,18]],"date-time":"2026-06-18T04:27:51Z","timestamp":1781756871505,"version":"3.54.5"},"reference-count":22,"publisher":"Springer Science and Business Media LLC","issue":"7","license":[{"start":{"date-parts":[[2019,10,2]],"date-time":"2019-10-02T00:00:00Z","timestamp":1569974400000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2019,10,2]],"date-time":"2019-10-02T00:00:00Z","timestamp":1569974400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Z Gerontol Geriat"],"published-print":{"date-parts":[[2019,11]]},"DOI":"10.1007\/s00391-019-01617-0","type":"journal-article","created":{"date-parts":[[2019,10,2]],"date-time":"2019-10-02T11:04:39Z","timestamp":1570014279000},"page":"701-712","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":2,"title":["Herzinsuffizienz im Alter","Heart failure in old age"],"prefix":"10.1007","volume":"52","author":[{"given":"Anne","family":"Lambrecht","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Roland","family":"Hardt","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2019,10,2]]},"reference":[{"issue":"8","key":"1617_CR1","doi-asserted-by":"publisher","first-page":"688","DOI":"10.1007\/s00392-015-0841-4","volume":"104","author":"C Ohlmeier","year":"2015","unstructured":"Ohlmeier\u00a0C, Mikolajczyk\u00a0R, Frick\u00a0J et al (2015) Incidence, prevalence and 1\u2011year all-cause mortality of heart failure in Germany: a\u00a0study based on electronic healthcare data of more than six million persons. Clin Res Cardiol 104(8):688\u2013696","journal-title":"Clin Res Cardiol"},{"issue":"9","key":"1617_CR2","doi-asserted-by":"publisher","first-page":"1137","DOI":"10.1136\/hrt.2003.025270","volume":"93","author":"A Mosterd","year":"2007","unstructured":"Mosterd\u00a0A, Hoes\u00a0AW (2007) Clinical epidemiology of heart failure. Heart 93(9):1137\u20131146","journal-title":"Heart"},{"issue":"5","key":"1617_CR3","doi-asserted-by":"publisher","first-page":"518","DOI":"10.1093\/eurjhf\/hfr021","volume":"13","author":"I Oudejans","year":"2011","unstructured":"Oudejans\u00a0I, Mosterd\u00a0A, Bloemen\u00a0JA et\u00a0al (2011) Clinical evaluation of geriatric outpatients with suspected heart failure: value of symptoms, signs, and additional tests. Eur J Heart Fail 13(5):518\u2013527","journal-title":"Eur J Heart Fail"},{"key":"1617_CR4","unstructured":"https:\/\/www.awmf.org\/uploads\/tx_szleitlinien\/nvl006l_S3_Chronische_Herzinsuffizienz_2018-04.pdf\n                    \n                  . Zugegriffen: 7. Juli 2019"},{"issue":"3","key":"1617_CR5","doi-asserted-by":"publisher","first-page":"251","DOI":"10.1056\/NEJMoa052256","volume":"355","author":"TE Owan","year":"2006","unstructured":"Owan\u00a0TE, Hodge\u00a0DO, Herges\u00a0RM et\u00a0al (2006) Trends in prevalence and outcome of heart failure with preserved ejection fraction. N\u00a0Engl J Med 355(3):251\u2013259","journal-title":"N Engl J Med"},{"issue":"23","key":"1617_CR6","doi-asserted-by":"publisher","first-page":"1429","DOI":"10.1056\/NEJM198706043162301","volume":"316","author":"CONSENSUS Trial Study Group","year":"1987","unstructured":"CONSENSUS Trial Study Group (1987) Effects of enalapril on mortality in severe congestive heart failure. Results of the Cooperative North Scandinavian Enalapril Survival Study (CONSENSUS). N\u00a0Engl J Med 316(23):1429\u20131435","journal-title":"N Engl J Med"},{"issue":"5","key":"1617_CR7","doi-asserted-by":"publisher","first-page":"293","DOI":"10.1056\/NEJM199108013250501","volume":"325","author":"S Yusuf","year":"1991","unstructured":"Yusuf\u00a0S, Pitt\u00a0B, Davis\u00a0CE, Hood\u00a0WB, Cohn\u00a0JN (1991) Effect of enalapril on survival in patients with reduced left ventricular ejection fractions and congestive heart failure. N\u00a0Engl J Med 325(5):293\u2013302","journal-title":"N Engl J Med"},{"issue":"24","key":"1617_CR8","doi-asserted-by":"publisher","first-page":"1883","DOI":"10.1093\/eurheartj\/ehx026","volume":"38","author":"W Ouwerkerk","year":"2017","unstructured":"Ouwerkerk\u00a0W, Voors\u00a0AA, Anker\u00a0SD et al (2017) Determinants and clinical outcome of uptitration of ACE-inhibitors and beta-blockers in patients with heart failure: a\u00a0prospective European study. Eur Heart\u00a0J 38(24):1883\u20131890","journal-title":"Eur Heart J"},{"key":"1617_CR9","doi-asserted-by":"crossref","unstructured":"The Cardiac Insufficiency Bisoprolol Study II (CIBIS-II): a\u00a0randomised trial (1999) Lancet 353(9146):9\u201313","DOI":"10.1016\/S0140-6736(98)11181-9"},{"issue":"17","key":"1617_CR10","doi-asserted-by":"publisher","first-page":"2194","DOI":"10.1161\/01.CIR.0000035653.72855.BF","volume":"106","author":"M Packer","year":"2002","unstructured":"Packer\u00a0M, Fowler\u00a0MB, Roecker\u00a0EB et\u00a0al (2002) Effect of carvedilol on the morbidity of patients with severe chronic heart failure: results of the carvedilol prospective randomized cumulative survival (COPERNICUS) study. Circulation 106(17):2194\u20132199","journal-title":"Circulation"},{"issue":"10","key":"1617_CR11","doi-asserted-by":"publisher","first-page":"1295","DOI":"10.1001\/jama.283.10.1295","volume":"283","author":"A Hjalmarson","year":"2000","unstructured":"Hjalmarson\u00a0A, Goldstein\u00a0S, Fagerberg\u00a0B et al (2000) Effects of controlled-release metoprolol on total mortality, hospitalizations, and well-being in patients with heart failure: the Metoprolol CR\/XL Randomized Intervention Trial in congestive heart failure (MERIT-HF). MERIT-HF Study Group. JAMA 283(10):1295\u20131302","journal-title":"JAMA"},{"issue":"3","key":"1617_CR12","doi-asserted-by":"publisher","first-page":"215","DOI":"10.1093\/eurheartj\/ehi115","volume":"26","author":"MD Flather","year":"2005","unstructured":"Flather\u00a0MD, Shibata\u00a0MC, Coats\u00a0AJ et\u00a0al (2005) Randomized trial to determine the effect of nebivolol on mortality and cardiovascular hospital admission in elderly patients with heart failure (SENIORS). Eur Heart\u00a0J 26(3):215\u2013225","journal-title":"Eur Heart J"},{"issue":"7","key":"1617_CR13","doi-asserted-by":"publisher","first-page":"820","DOI":"10.1093\/eurheartj\/ehq502","volume":"32","author":"B Pitt","year":"2011","unstructured":"Pitt\u00a0B, Anker\u00a0SD, Bushinsky\u00a0DA et al (2011) Evaluation of the efficacy and safety of RLY5016, a\u00a0polymeric potassium binder, in a\u00a0double-blind, placebo-controlled study in patients with chronic heart failure (the PEARL-HF) trial. Eur Heart\u00a0J 32(7):820\u2013828","journal-title":"Eur Heart J"},{"issue":"11","key":"1617_CR14","doi-asserted-by":"publisher","first-page":"1296","DOI":"10.1093\/eurjhf\/hft102","volume":"15","author":"L Tavazzi","year":"2013","unstructured":"SHIFT Investigators, Tavazzi\u00a0L, Swedberg\u00a0K, Komajda\u00a0M et\u00a0al (2013) Efficacy and safety of ivabradine in chronic heart failure across the age spectrum: insights from the SHIFT study. Eur J Heart Fail 15(11):1296\u20131303","journal-title":"Eur J Heart Fail"},{"issue":"11","key":"1617_CR15","doi-asserted-by":"publisher","first-page":"993","DOI":"10.1056\/NEJMoa1409077","volume":"371","author":"JJ McMurray","year":"2014","unstructured":"PARADIGM-HF Investigators and Committees, McMurray\u00a0JJ, Packer\u00a0M, Desai\u00a0AS et al (2014) Angiotensin-neprilysin inhibition versus enalapril in heart failure. N\u00a0Engl J Med 371(11):993\u20131004","journal-title":"N Engl J Med"},{"issue":"38","key":"1617_CR16","doi-asserted-by":"publisher","first-page":"2576","DOI":"10.1093\/eurheartj\/ehv330","volume":"36","author":"PS Jhund","year":"2015","unstructured":"Jhund\u00a0PS, Fu\u00a0M, Bayram\u00a0E, PARADIGM-HF Investigators and Committees et al (2015) Efficacy and safety of LCZ696 (sacubitril-valsartan) according to age: insights from PARADIGM-HF. Eur Heart\u00a0J 36(38):2576\u20132584","journal-title":"Eur Heart J"},{"issue":"8","key":"1617_CR17","doi-asserted-by":"publisher","first-page":"1072","DOI":"10.1002\/ejhf.584","volume":"18","author":"KF Adams","year":"2016","unstructured":"Adams\u00a0KF, Butler\u00a0J, Patterson\u00a0JH et\u00a0al (2016) Dose response characterization of the association of serum digoxin concentration with mortality outcomes in the Digitalis Investigation Group trial. Eur J Heart Fail 18(8):1072\u20131081","journal-title":"Eur J Heart Fail"},{"issue":"12","key":"1617_CR18","doi-asserted-by":"publisher","first-page":"1574","DOI":"10.1002\/ejhf.813","volume":"19","author":"O Chioncel","year":"2017","unstructured":"Chioncel\u00a0O, Lainscak\u00a0M, Seferovic\u00a0PM et al (2017) Epidemiology and one-year outcomes in patients with chronic heart failure and preserved, mid-range and reduced ejection fraction: an analysis of the ESC Heart Failure Long-Term Registry. Eur J Heart Fail 19(12):1574\u20131585","journal-title":"Eur J Heart Fail"},{"issue":"18","key":"1617_CR19","doi-asserted-by":"publisher","first-page":"1887","DOI":"10.1056\/NEJMoa0801369","volume":"358","author":"NS Beckett","year":"2008","unstructured":"HYVET Study Group, Beckett\u00a0NS, Peters\u00a0R, Fletcher\u00a0AE et\u00a0al (2008) Treatment of hypertension in patients 80 years of age or older. N\u00a0Engl J Med 358(18):1887\u20131898","journal-title":"N Engl J Med"},{"issue":"1","key":"1617_CR20","doi-asserted-by":"publisher","first-page":"33","DOI":"10.1161\/CIRCHEARTFAILURE.114.001615","volume":"8","author":"A Pandey","year":"2015","unstructured":"Pandey\u00a0A, Parashar\u00a0A, Kumbhani\u00a0D et al (2015) Exercise training in patients with heart failure and preserved ejection fraction: meta-analysis of randomized controlled trials. Circ Heart Fail 8(1):33\u201340","journal-title":"Circ Heart Fail"},{"key":"1617_CR21","unstructured":"https:\/\/www.leitlinien.de\/mdb\/downloads\/nvl\/herzinsuffizienz\/herzinsuffizienz-3aufl-konsultation.pdf\n                    \n                  . Zugegriffen: 7. Juli 2019"},{"issue":"24","key":"1617_CR22","doi-asserted-by":"publisher","first-page":"2307","DOI":"10.1056\/NEJMoa1806640","volume":"379","author":"GW Stone","year":"2018","unstructured":"COAPT Investigators, Stone\u00a0GW, Lindenfeld\u00a0J, Abraham\u00a0WT et al (2018) Transcatheter Mitral-Valve Repair in Patients with Heart Failure. N\u00a0Engl J Med 379(24):2307\u20132318","journal-title":"N Engl J Med"}],"container-title":["Zeitschrift f\u00fcr Gerontologie und Geriatrie"],"original-title":[],"language":"de","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00391-019-01617-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00391-019-01617-0\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00391-019-01617-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,9,30]],"date-time":"2020-09-30T23:37:28Z","timestamp":1601509048000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00391-019-01617-0"}},"subtitle":["Aktuelle Empfehlungen mit Blick auf die \u00fcberarbeitete Nationale VersorgungsLeitlinie Chronische Herzinsuffizienz","Current recommendations in view of the revised national treatment guidelines on chronic heart failure"],"short-title":[],"issued":{"date-parts":[[2019,10,2]]},"references-count":22,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2019,11]]}},"alternative-id":["1617"],"URL":"https:\/\/doi.org\/10.1007\/s00391-019-01617-0","relation":{},"ISSN":["0948-6704","1435-1269"],"issn-type":[{"value":"0948-6704","type":"print"},{"value":"1435-1269","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019,10,2]]},"assertion":[{"value":"9 July 2019","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"2 September 2019","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"2 October 2019","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Einhaltung ethischer Richtlinien"}},{"value":"Gem\u00e4\u00df den Richtlinien des Springer Medizin Verlags werden Autoren und Wissenschaftliche Leitung im Rahmen der Manuskripterstellung und Manuskriptfreigabe aufgefordert, eine vollst\u00e4ndige Erkl\u00e4rung zu ihren finanziellen und nichtfinanziellen Interessen abzugeben.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Interessenkonflikt"}},{"value":"<b>A.\u00a0Lambrecht<\/b> gibt an, dass kein finanzieller Interessenkonflikt besteht. Nichtfinanzielle Interessen: angestellte \u00c4rztin\/Universit\u00e4tsmedizin Mainz\/bis 14.07.2016 als Assistenz\u00e4rztin im Zentrum f\u00fcr Kardiologie\/seit 15.07.2016 als Funktionsober\u00e4rztin in der Abteilung f\u00fcr Geriatrie\/seit 01.11.2018 als Ober\u00e4rztin in der Abteilung f\u00fcr Geriatrie | \u2013 Mitgliedschaften: Deutsche Gesellschaft f\u00fcr Innere Medizin (DGIM); Deutsche Gesellschaft f\u00fcr Geriatrie (DGG). <b>R.\u00a0Hardt<\/b>: Finanzielle Interessen: Forschungsf\u00f6rderung zur pers\u00f6nlichen Verf\u00fcgung: Alexander Karl Stiftung Mainz: finanzielle F\u00f6rderung zur Anschaffung von Medizinger\u00e4ten f\u00fcr die Abteilung Geriatrie | Innovationsfond: F\u00f6rderung des Projektes \u201eGerNe\u201c (neue Versorgungsformen). \u2013 Referentenhonorar oder Kostenerstattung als passiver Teilnehmer: Firmen: Bayes Vital, Daiichi Sankyo, Bristol Myers Squibb, Novartis, Pfizer, Sanofi MSD Pasteur: | Referentenhonorare, Reisekostenerstattung. \u2013 Bezahlter Berater\/interner Schulungsreferent\/Gehaltsempf\u00e4nger o.\u202f\u00c4.: Advisory Boards f\u00fcr Sanofi MSD Pasteur, Daiichi Sankyo, Bayer Vital. Nichtfinanzielle Interessen: angestellter Arzt, Leiter der Abteilung Geriatrie des Zentrums f\u00fcr Allgemeinmedizin und Geriatrie der Universit\u00e4tsmedizin Mainz | Mitgliedschaft in folgenden med. Fachgesellschaften: Deutsche Gesellschaft f\u00fcr Geriatrie; Deutsche Gesellschaft f\u00fcr Gerontologie und Geriatrie; Deutsche Gesellschaft f\u00fcr Kardiologie; Deutsche Kontinenz Gesellschaft; Medizinische Gesellschaft Mainz; Marburger Bund.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Autoren"}},{"value":"Die vollst\u00e4ndige Erkl\u00e4rung zum Interessenkonflikt der Wissenschaftlichen Leitung finden Sie am Kurs der zertifizierten Fortbildung auf .","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Wissenschaftliche Leitung"}},{"value":"erkl\u00e4rt, dass f\u00fcr die Publikation dieser CME-Fortbildung keine Sponsorengelder an den Verlag flie\u00dfen.","order":5,"name":"Ethics","group":{"name":"EthicsHeading","label":"Der Verlag"}},{"value":"F\u00fcr diesen Beitrag wurden von den Autoren keine Studien an Menschen oder Tieren durchgef\u00fchrt. F\u00fcr die aufgef\u00fchrten Studien gelten die jeweils dort angegebenen ethischen Richtlinien.","order":6,"name":"Ethics","group":{"name":"EthicsHeading","label":"Der Verlag"}}]}}